240
Participants
Start Date
December 31, 2015
Primary Completion Date
February 8, 2018
Study Completion Date
February 8, 2018
Rostafuroxin
This is a potent, selective and safe inhibitor of this altered mechanism and has been proved to be effective in reducing blood pressure levels in Adducin mutated rat strains and in chronic Ouabain infused rat model.
Losartan
COZAAR (losartan potassium) is an angiotensin II receptor (type AT1) antagonist. Losartan potassium, a nonpeptide molecule, is chemically described as 2-butyl-4-chloro-1-\[p-(o-1H-tetrazol-5-ylphenyl)benzyl\]imidazole- 5-methanol monopotassium salt.
Cvie Therapeutics Limited, Taipei
Lead Sponsor
Windtree Therapeutics
INDUSTRY